FIELD: chemistry, biochemistry.
SUBSTANCE: invention relates to virology and genetic engineering. Claimed is recombinant virus of fowl pox, inducing immune response against hepatitis C (HCV) virus, containing DNA-fragment obtained from HCV. Said DNA-fragment codes fragment core-E1 polyprotein or chimeric protein, containing HCV epitopes, specific to helper and cytotoxic T-cells. Also claimed is pharmaceutical composition containing such virus.
EFFECT: invention can be used in medicine.
9 cl, 8 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
| MODIFIED VARIANT OF ANKARA VACCINA VIRUS | 2001 |
|
RU2290438C2 |
| CR3 CHIMERA GENE AND CR3 CHIMERA PROTEIN ENCODED THEREWITH (VARIANTS) INDUCING ANTI-HIV-1 IMMUNE RESPONSE | 2002 |
|
RU2302461C2 |
| CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS | 2013 |
|
RU2639504C2 |
| MUTANT HERPES VIRUS-COMPRISING VACCINE | 1991 |
|
RU2236256C2 |
| VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
| RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS | 2002 |
|
RU2270860C2 |
| ALTERNATED STRAIN OF MODIFIED VACCINIA VIRUS ANKARA (MVA) | 2001 |
|
RU2280075C2 |
| VACCINE AGAINST FROM WEST NILE ENCEPHALITIS VIRUS | 2002 |
|
RU2283138C2 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
